Research Article| Volume 12, ISSUE 5, P297-300, October 1984

Download started.


Should your hospital's employees receive pantitis B vaccine?

      This paper is only available as a PDF. To read, Please Download here.


      The hepatitis B risk for hospital employees is a function of their own prior experience with this disease and their frequency of exposure to patient blood, plus characteristics of the hospital's patient population, services, and prevention policies. Assessment of the hospital's risk includes consideration of costs associated with employee cases of hepatitis B, employee turnover rates, frequency of exposure incidents, and costs for preexposure and postexposure hepatitis B prevention policies. Benefits occur for both employee and hospital when the risk of hepatitis B transmission is minimized. Each institution must remember that it does not operate in isolation; its policies will be compared to those of other health care organizations. Participation in community efforts to develop local standards is advisable, but administrators should also recognize the possibility of having unique groups of high-risk employees in their own hospital. Analysis of each of the twelve issues will provide hospital decision-makers with information needed to select appropriate hepatitis B prevention strategies for their institution. This information should help in the development of a plan that will balance the costs and benefits of hepatitis B vaccine and, at the same time, protect employees from this occupational health problem.
      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'


      Subscribe to American Journal of Infection Control
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect


        • Dienstag J.
        • Ryan D.
        Occupational exposure to hepatitis B virus in hospital personnel: Infection or immunization?.
        Am J Epidemiol. 1982; 115: 26-39
        • Maynard J.E.
        Viral hepatitis as an occupational hazard in the health care profession.
        in: Vyas G.N. Cohen S.N. Schmid R. Viral hepatitis: Etiology, epidemiology, pathogenesis and prevention. Franklin Institute Press, Philadelphia1978
        • Pattison C.
        • Maynard J.
        • Berquist K.
        • et al.
        Epidemiology of hepatitis B in hospital personnel.
        Am J Epidemiol. 1975; 101: 59-64
        • Hansen J.
        • Falconer J.
        • Hamilton J.
        • et al.
        Hepatitis B in a medical center.
        JOM. 1981; 23: 338-342
        • Krugman S.
        The newly licensed hepatitis B vaccine: Characteristics and indications for use.
        JAMA. 1982; 247: 2012-2015
        • Alter H.
        • Chalmers T.
        • Freeman B.
        • et al.
        Health-care workers positive for hepatitis B surface antigen: Are their contacts at risk?.
        N Engl J Med. 1975; 292: 454-457
        • Centers for Disease Control
        Inactivated hepatitis B virus vaccine.
        Morbid Mortal Weekly Rep. 1982; 31: 317-331
        • Linnemann Jr., C.
        • Hegg M.
        • Ramundo N.
        • et al.
        Screening hospital patients for hepatitis B surface antigen.
        Am J Clin Pathol. 1977; 67: 257-259
        • Mahoney J.
        • Richman A.
        • Teague P.
        Admission screening for hepatitis B surface antigen in a university hospital.
        South Med J. 1978; 71: 624-629
        • Grady G.
        Hepatitis B immunity in hospital staff targeted for vaccination: Role of screening tests in immunization programs.
        JAMA. 1982; 248: 2266-2269
        • Snydman D.
        • Bryan J.
        • Dixon R.
        Prevention of nosocomial viral hepatitis, type B (hepatitis B).
        Ann Intern Med. 1975; 83: 838-845
        • Koff R.
        Viral hepatitis.
        John Wiley & Sons, Inc, New York1978
        • Dandoy S.
        • Kirkman-Liff B.L.
        Incidence and costs of hepatitis B in health care personnel in Arizona.
        Arizona Med. 1983; 40: 835-838
        • Mulley A.
        • Silverstein M.
        • Dienstag J.
        Indications for use of hepatitis B vaccine, based on cost-effectiveness analysis.
        N Engl J Med. 1982; 307: 644-652
        • Hashimoto F.
        Cost effectiveness of serotesting before hepatitis vaccination (letter).
        N Engl J Med. 1982; 307: 503
      1. Dandoy S, Kirkman-Lift BL, Krakowski FM: Hepatitis B exposure incidents in community hospitals. Am J Public Health (in press).

        • Reed J.
        • Anderson A.
        • Hodges G.
        Needlestick and puncture wounds: Definition of the problem.
        Am J Infect Control. 1980; 8: 101-106
        • McCormick R.
        • Maki D.
        Epidemiology of needlestick injuries in hospital personnel.
        Am J Med. 1981; 70: 928-932
        • Centers for Disease Control
        Immune globulins for protection against viral hepatitis.
        Morbid Mortal Weekly Rep. 1981; 30: 423-428
        • Dandoy S.
        • Kirkman-Liff B.L.
        • Krakowski F.M.
        Hepatitis B exposure of multiple hospital employees: Five case studies.
        Arch Intern Med. 1984; 144: 720-723